Safety, efficacy and pharmacokinetics of recombinant factor IX FC fusion protein in children with haemophilia B (KIDS B-LONG)

被引：0
|
作者：
Fischer, K. [1 ]
Kulkarni, R. [2 ]
Nolan, B. [3 ]
Mahlangu, J. [4 ]
Rangarajan, S. [5 ]
Gambino, G. [6 ]
Diao, L. [6 ]
Cristiano, L. M. [6 ]
Pierce, G. F. [6 ]
Allen, G. [6 ]
机构：
[1] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[2] Michigan State Univ, Lansing, MI USA
[3] Our Ladys Childrens Hosp, Dublin, Ireland
[4] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[5] Basingstoke & North Hampshire Hosp, Basingstoke, Hants, England
[6] Biogen Idec Inc, Cambridge, MA USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
LB009
引用
收藏
页码：87 / 87
页数：1
相关论文
共 50 条
  • [1] Long-term efficacy and safety of prophylactic treatment with recombinant factor IX FC fusion protein (rFIXFc) in subjects with severe or moderate haemophilia B: final longitudinal analysis of B-LONG/kids B-LONG and B-YOND
    Shapiro, A. D.
    Kulkarni, R.
    Ragni, M. V.
    Mahlangu, J.
    Oldenburg, J.
    Nolan, B.
    Ozelo, M. C.
    Willemze, A.
    Feng, J.
    Barnowski, C.
    Barnes, C.
    HAEMOPHILIA, 2019, 25 : 39 - 40
  • [2] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in children with hemophilia B: Longitudinal analysis of kids B-LONG and B-YOND
    Bennett, Carolyn M.
    Nolan, Beatrice
    Kulkarni, Roshni
    Fischer, Kathelijn
    Perry, David J.
    Barnes, Christopher
    Feng, Jingyuan
    Ferrante, Francesca
    Ramirez-Santiago, Alejandra
    Mei, Baisong
    Barnowski, Chris
    Allen, Geoffrey
    HAEMOPHILIA, 2016, 22 : 47 - 47
  • [3] Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: A Interim Analysis Of The Kids B-LONG Study
    Fischer, Kathelijn
    Kulkarni, Roshni
    Bradbury, Myles
    Ragni, Margaret V.
    Rangarajan, Savita
    Dong, Yingwen
    Li, Shuanglian
    Jiang, Haiyan
    Nugent, Karen
    Pierce, Glenn F.
    Allen, Geoffrey
    BLOOD, 2013, 122 (21)
  • [4] Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study
    Fischer, Kathelijn
    Kulkarni, Roshni
    Nolan, Beatrice
    Mahlangu, Johnny
    Rangarajan, Savita
    Gambino, Giulia
    Diao, Lei
    Ramirez-Santiago, Alejandra
    Pierce, Glenn F.
    Allen, Geoffrey
    LANCET HAEMATOLOGY, 2017, 4 (02): : E75 - E82
  • [5] Long-term Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Adults, Adolescents, and Children With Hemophilia B: Longitudinal Analysis of B-LONG, Kids B-LONG, and B-YOND
    Kulkarni, R.
    Ragni, M.
    Mahlangu, J.
    Shapiro, A.
    Oldenburg, J.
    Matsushita, T.
    Nolan, B.
    Feng, J.
    Winding, B.
    Ramirez-Santiago, A.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 23 - 24
  • [6] B-LONG: results from a Phase 3 study of safety, efficacy, and pharmacokinetics of long-lasting recombinant factor IX Fc Fusion Protein (rFIXFc)
    Powell, J.
    Ozelo, M. C.
    Pasi, J.
    Ragni, M.
    Valentino, L. A.
    Mahlangu, J.
    Manco-Johnson, M.
    Josephson, N.
    Perry, D.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 240 - 240
  • [7] Low Bleeding Rates with Increase or Maintenance of Physical Activity in Patients Treated with Recombinant Factor IX FC Fusion Protein (rFIXFc) in the B-LONG and Kids B-LONG Studies
    Windyga, J.
    Kulkarni, R.
    Shapiro, A. D.
    Ragni, M. V.
    Pasi, K. J.
    Ozelo, M. C.
    Tsao, E.
    Allen, G.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 19 - 20
  • [8] Low Bleeding Rates with Increase or Maintenance of Physical Activity in Patients Treated with Recombinant Factor IX Fc Fusion Protein ( rFIXFc) in the B-LONG and Kids B-LONG Studies
    Kulkarni, Roshni
    Shapiro, Amy D.
    Windyga, Jerzy
    Ragni, Margaret V.
    Pasi, K. John
    Ozelo, Margareth Castro
    Tsao, Elisa
    Mei, Baisong
    BLOOD, 2015, 126 (23)
  • [9] Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
    Powell, Jerry S.
    Apte, Shashikant
    Chambost, Herve
    Hermans, Cedric
    Jackson, Shannon
    Josephson, Neil C.
    Mahlangu, Johnny N.
    Ozelo, Margareth C.
    Peerlinck, Kathelijne
    Pasi, John
    Perry, David
    Ragni, Margaret V.
    Wang, Xuefeng
    Jiang, Haiyan
    Li, Shuanglian
    Cristiano, Lynda M.
    Innes, Alison
    Nugent, Karen
    Brennan, Aoife
    Luk, Alvin
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 124 - 134
  • [10] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) in adults/adolescents with hemophilia B: Longitudinal analysis of B-LONG and B-YOND
    Mahlangu, Johnny
    Ragni, Margaret V.
    Shapiro, Amy D.
    Pasi, K. John
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Matsushita, Tadashi
    Baker, Ross I.
    Feng, Ingyuan
    Ferrante, Francesca
    Ramirez-Santiago, Alejandra
    Mei, Baisong
    Barnowski, Chris
    HAEMOPHILIA, 2016, 22 : 47 - 47
12345